3 Stocks Pushing The Health Care Sector Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 25 points (-0.2%) at 14,513 as of Friday, March 15, 2013, 12:49 PM ET. The NYSE advances/declines ratio sits at 1,309 issues advancing vs. 1,578 declining with 140 unchanged.

The Health Care sector currently sits down 0.1% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the sector include Intuitive Surgical ( ISRG), down 4.8%, Edwards Life ( EW), down 2.8%, Stryker Corporation ( SYK), down 1.0%, Baxter International ( BAX), down 1.1% and Amgen ( AMGN), down 0.8%.

TheStreet Ratings group would like to highlight 3 stocks pushing the sector lower today:

3. Teva Pharmaceutical Industries ( TEVA) is one of the companies pushing the Health Care sector lower today. As of noon trading, Teva Pharmaceutical Industries is down $0.27 (-0.7%) to $40.79 on light volume Thus far, 1.6 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $40.78-$41.16 after having opened the day at $41.10 as compared to the previous trading day's close of $41.06.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $34.9 billion and is part of the drugs industry. The company has a P/E ratio of 18.1, above the S&P 500 P/E ratio of 17.7. Shares are up 10.0% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full Teva Pharmaceutical Industries Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

CEOs Are Dropping Like Flies

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

S&P 500 and Dow Aim for New Records With Broad-Based Gains Ahead of Fed

Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed